×
About 7,079 results

ALLMedicine™ Endometrial Carcinoma Center

Research & Reviews  3,479 results

TPPP3 inhibits the proliferation, invasion and migration of endometrial carcinoma targe...
https://doi.org/10.1111/1440-1681.13456
Clinical and Experimental Pharmacology & Physiology; Shen A, Tong X et. al.

Mar 1st, 2021 - Database screening indicated that tubulin polymerization-promoting protein 3 (TPPP3) was involved in pathogenesis of multiple cancer types. miR-1827 has a potential role in a variety of human cancers. However, the role of TPPP3 and its underlying ...

Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its...
https://doi.org/10.1007/s12094-021-02572-2 10.3322/caac.21262 10.3322/caac.21254 10.1097/PGP.0000000000000124 10.1016/j.tcb.2014.12.004 10.3892/ijo.2016.3802 10.1038/cddiscovery.2017.39 10.1158/0008-5472.CAN-17-0112 10.1007/s13277-015-4116-5 10.1002/ijc.11101 10.1097/COC.0b013e31829a2974 10.1097/CEJ.0000000000000178 10.1186/s13046-018-0828-x 10.3390/ijms19041116 10.1093/biolre/iox139 10.1016/j.prp.2018.10.025
Clinical & Translational Oncology : Official Publication ... Hu Y, Yu L et. al.

Feb 26th, 2021 - To investigate the expression of bone morphogenetic protein 10 (BMP-10) in patients with endometrial carcinoma (EC) and its clinical significance. Totally 143 cancer tissue specimens were sampled from patients with EC and retrospectively analyzed....

Prevalence and risk factors for malignancy in hysteroscopy resected endometrial polyps.
https://doi.org/10.1002/ijgo.13656
International Journal of Gynaecology and Obstetrics: the ... Wong CLH, So PL

Feb 23rd, 2021 - Endometrial polyps are generally benign, but can evolve into premalignant or malignant lesions. The primary aim of this study is to determine the prevalence of malignant lesions in endometrial polyps by hysteroscopic polypectomy, and risk factors ...

Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
https://doi.org/10.1016/j.prp.2021.153374
Pathology, Research and Practice; Xu J, Jia Q et. al.

Feb 23rd, 2021 - RSK4 refers to one Ser/Thr protein kinase functioning downstream pertaining to the signaling channel of protein kinase (MAPK) stimulated by Ras/mitogen. RSK4 can regulate numerous substrates impacting cells' surviving state, growing processes and ...

Development of a novel immune-related lncRNA signature as a prognostic classifier for e...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893582
International Journal of Biological Sciences; Liu J, Mei J et. al.

Feb 22nd, 2021 - Endometrial carcinoma (EnCa) is one of the deadliest gynecological malignancies. The purpose of the current study was to develop an immune-related lncRNA prognostic signature for EnCa. In the current research, a series of systematic bioinformatics...

see more →

Guidelines  21 results

ACR Appropriateness Criteria® Pretreatment Evaluation and Follow-Up of Endometrial Cancer.
https://doi.org/10.1016/j.jacr.2020.09.001
Journal of the American College of Radiology : JACR; , Reinhold C et. al.

Nov 6th, 2020 - To date, there is little consensus on the role of pelvic imaging in assessing local disease extent during initial staging in patients with endometrial carcinoma, with practices differing widely across centers. However, when pretreatment assessment...

FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
https://www.mrknewsroom.com/news-release/oncology/fda-approves-keytruda-pembrolizumab-plus-lenvima-lenvatinib-combination-treatm

Sep 16th, 2019 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available ki...

Impact of TP53 immunohistochemistry on the histological grading system for endometrial endometrioid carcinoma
https://www.nature.com/articles/s41379-019-0220-1
Yano,M.,et al

Feb 10th, 2019 - Endometrial endometrioid carcinoma is usually divided into three histological subgroups: grade 1 (G1), grade 2 (G2), and grade 3 (G3). Most cases of endometrial endometrioid carcinoma G1/2 have a favorable prognosis, although some can have unfavor...

The Role of Transvaginal Ultrasonography in Evaluating the Endometrium of Women With Postmen...
https://www.acog.org/Clinical-Guidance-and-Publications/Committee-Opinions/Committee-on-Gynecologic-Practice/The-Role-of-Transvaginal-Ultrasonography-in-Evaluating-the-Endometrium-of-Women-With-Postmenopausal
Committee on Gynecologic Practice

Apr 30th, 2018 - Cancer of the endometrium is the most common type of gynecologic cancer in the United States. Vaginal bleeding is the presenting sign in more than 90% of postmenopausal women with endometrial carcinoma.

Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology
http://www.jnccn.org/content/16/2/170.full
Koh, W.

Jan 31st, 2018 - Endometrial carcinoma is a malignant epithelial tumor that forms in the inner lining, or endometrium, of the uterus. Endometrial carcinoma is the most common gynecologic malignancy.

see more →

Drugs  1 results see all →

Clinicaltrials.gov  3,533 results

TPPP3 inhibits the proliferation, invasion and migration of endometrial carcinoma targe...
https://doi.org/10.1111/1440-1681.13456
Clinical and Experimental Pharmacology & Physiology; Shen A, Tong X et. al.

Mar 1st, 2021 - Database screening indicated that tubulin polymerization-promoting protein 3 (TPPP3) was involved in pathogenesis of multiple cancer types. miR-1827 has a potential role in a variety of human cancers. However, the role of TPPP3 and its underlying ...

Expression of bone morphogenetic protein 10 in cases with endometrial carcinoma and its...
https://doi.org/10.1007/s12094-021-02572-2 10.3322/caac.21262 10.3322/caac.21254 10.1097/PGP.0000000000000124 10.1016/j.tcb.2014.12.004 10.3892/ijo.2016.3802 10.1038/cddiscovery.2017.39 10.1158/0008-5472.CAN-17-0112 10.1007/s13277-015-4116-5 10.1002/ijc.11101 10.1097/COC.0b013e31829a2974 10.1097/CEJ.0000000000000178 10.1186/s13046-018-0828-x 10.3390/ijms19041116 10.1093/biolre/iox139 10.1016/j.prp.2018.10.025
Clinical & Translational Oncology : Official Publication ... Hu Y, Yu L et. al.

Feb 26th, 2021 - To investigate the expression of bone morphogenetic protein 10 (BMP-10) in patients with endometrial carcinoma (EC) and its clinical significance. Totally 143 cancer tissue specimens were sampled from patients with EC and retrospectively analyzed....

Prevalence and risk factors for malignancy in hysteroscopy resected endometrial polyps.
https://doi.org/10.1002/ijgo.13656
International Journal of Gynaecology and Obstetrics: the ... Wong CLH, So PL

Feb 23rd, 2021 - Endometrial polyps are generally benign, but can evolve into premalignant or malignant lesions. The primary aim of this study is to determine the prevalence of malignant lesions in endometrial polyps by hysteroscopic polypectomy, and risk factors ...

Prominent roles of ribosomal S6 kinase 4 (RSK4) in cancer.
https://doi.org/10.1016/j.prp.2021.153374
Pathology, Research and Practice; Xu J, Jia Q et. al.

Feb 23rd, 2021 - RSK4 refers to one Ser/Thr protein kinase functioning downstream pertaining to the signaling channel of protein kinase (MAPK) stimulated by Ras/mitogen. RSK4 can regulate numerous substrates impacting cells' surviving state, growing processes and ...

Development of a novel immune-related lncRNA signature as a prognostic classifier for e...
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7893582
International Journal of Biological Sciences; Liu J, Mei J et. al.

Feb 22nd, 2021 - Endometrial carcinoma (EnCa) is one of the deadliest gynecological malignancies. The purpose of the current study was to develop an immune-related lncRNA prognostic signature for EnCa. In the current research, a series of systematic bioinformatics...

see more →

News  45 results

The role of hysteroscopy in diagnosing endometrial cancer
https://www.mdedge.com/obgyn/article/218597/gynecologic-cancer/role-hysteroscopy-diagnosing-endometrial-cancer/page/0/3?channel=217

Mar 6th, 2020 - Potential for intraperitoneal dissemination of endometrial cancer There is some concern about intraperitoneal dissemination of endometrial carcinoma at the time of hysteroscopy and effect on disease prognosis. Chang and colleagues conducted a larg.

Proteogenomics provides molecular insights into endometrial carcinoma
https://www.mdedge.com/hematology-oncology/article/217509/gynecologic-cancer/proteogenomics-provides-molecular-insights?channel=39313
Caleb Rans

Feb 19th, 2020 - Newly discovered insights into the underlying molecular and immune mechanisms of endometrial carcinoma may reveal novel therapeutic targets and improve immunotherapy selection for patients, according to a proteogenomic study. Further insights into.

FDA approves pembrolizumab/lenvatinib combo for advanced endometrial carcinoma
https://www.mdedge.com/obgyn/article/208299/gynecologic-cancer/fda-approves-pembrolizumab/lenvatinib-combo-advanced?channel=27979
Lucas Franki

Sep 17th, 2019 - The Food and Drug Administration has granted accelerated approval to a pembrolizumab (Keytruda) plus lenvatinib (Lenvima) combination for the treatment of patients with advanced endometrial carcinoma that is not microsatellite instability high or.

FDA Approves KEYTRUDA® (pembrolizumab) plus LENVIMA® (lenvatinib) Combination Treatment for Patients with Certain Types of Endometrial Carcinoma
https://www.mrknewsroom.com/news-release/oncology/fda-approves-keytruda-pembrolizumab-plus-lenvima-lenvatinib-combination-treatm

Sep 16th, 2019 - Merck (NYSE: MRK), known as MSD outside the United States and Canada, and Eisai today announced that the U.S. Food and Drug Administration (FDA) approved the combination of KEYTRUDA, Merck’s anti-PD-1 therapy, plus LENVIMA, the orally available ki...

US, Canada, Australia Simultaneously Approve Endometrial Cancer Combo
https://www.medscape.com/viewarticle/918531

Sep 16th, 2019 - The US Food and Drug Administration (FDA), the Australian Therapeutic Goods Administration (TGA), and Health Canada (HC) today simultaneously approved a new two-drug combination for the treatment of advanced endometrial carcinoma. The three agenci...

see more →